LoneStar Heart Lands $20,000,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bee7b44a-c5ed-4cc1-bb5e-19331f87a45b&Preview=1 - Date
10/10/2012 - Company Name
LoneStar Heart - Mailing Address
26051 Merit Circle Laguna Hills, CA 92653 - Company Description
LoneStar Heart, Inc. is a Texas and California based biomedical company developing new therapies to preserve and restore adequate heart function in patients with Advanced Heart Failure (HF). - Website
http://www.lonestarheartinc.com - Transaction Type
Venture Equity - Transaction Amount
$20,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
LoneStar Heart Inc. today announced the completion of an up to $20 million milestone-based equity financing to support the clinical testing andregulatory clearance of its lead product, Algisyl-LVR, a single-use, self-gelling biopolymerimplanted into the heart’s left ventricle during surgery for the treatment of advanced heart failure. - M&A Terms
- Venture Investor
Themes Investment Partners - Venture Investor
Undisclosed
